The prevalence of human immunodeficiency virus (HIV) infection, lower genital tract infections (LGTIs), and their associated risk behaviors is high among incarcerated women in the United States. Correctional systems do not have a standardized program of LGTI screening and treatment. Because many LGTIs are asymptomatic, opportunities to detect and treat such infections in incarcerated women are often missed. This study compares the prevalence of LGTIs and risk factors among 20 HIV-seropositive and 40 HIV-seronegative incarcerated women in Rhode Island. Recommendations based on this data and other relevant studies are given regarding LGTI screening in jails and prisons.
Get full access to this article
View all access options for this article.
References
1.
Beck, A. J., & Karberg, J. C. (2001, March). Prison and jail inmates at midyear 2000 (Bureau of Justice Statistics Bulletin, NCJ 185989). Washington, DC: U.S. Department of Justice, Office of Justice Programs.
2.
BlankS., SternbergM., Neylans, L. L., Rubin, S. R., Weisfuse, I. B., & St. Louis, M. E. (1999). Incident syphilis among women with multiple admissions to jail in New York City. Journal ofInfectious Diseases, 180, 1159-1163.
3.
Centers for Disease Control and Prevention. (1998a). Assessment of sexually transmitted diseases services in city and county jails—United States, 1997. MMWR, 47(21), 429-431.
4.
Centers for Disease Control and Prevention. (1998b). HIV prevention through early detection and treatment of other sexually transmitted diseases—United States. MMWR, 47(RR-12), 1-7.
5.
Centers for Disease Control and Prevention. (1998c). Syphilis screening among women arrestees at the Cook County Jail—Chicago, 1996. MMWR, 47(21), 432-432.
6.
Centers for Disease Control and Prevention. (1999). High prevalence of chlamydial and gonococcal infection in women entering jails and juvenile detention centers—Chicago, Birmingham, and San Francisco, 1998. MMWR, 48(36), 793-796.
7.
Cohen, C. R., Plummer, F. A., MugoN., MacleanI., ShenC., Bukusi, E. A., et al. (1999). Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: A mechanism for enhanced HIV-1 transmission?. AIDS, 13, 327-332.
8.
Cotton-Oldenburg, N. U., Jordan, B. K., Martin, S. L.,& KupperL. (1999). Women inmates’ risky sex and drug behaviors: Are they related?. American Journal of Drug and Alcohol Abuse, 25(1), 129-149.
9.
Cotton-Oldenburg, N. U., Jordan, B. K., Martin, S. L.,& Sadowski, L. S. (1999). Voluntary HIV testing in prison: Do women inmates at high risk for HIV accept HIV testing?. AIDS Education and Prevention, 11(1), 28-37.
10.
Cu-UvinS., Hogan, J. W., Caliendo, A. M., HarwellJ., Mayer, K. H.,& Carpenter, C. C. J. (2001). Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clinical Infectious Diseases, 33(6), 894-896.
11.
Dean-Gaitor, H. D.,& Fleming, P. L. (1999). Epidemiology of AIDS in incarcerated persons in the United States, 1994-1996. AIDS, 13, 2429-2435.
12.
Farley, J. L., Mitty, J. A., Lally, M. A., Burzynski, J. N., TashimaK., Rich, J. D., et al. (2000). Comprehensive medical care among HIV-positive incarcerated women: The Rhode Island experience. Journal of Women’ Health and Gender-Based Medicine, 9(1), 51-56.
13.
Flanigan, T. P., Kim, J. Y., ZierlerS., RichJ., VigilanteK.,& Bury-MaynardD. (1996). A prison-release program for HIV-positive women: Linking them to health services and community follow-up. American Journal of Public Health, 86(6), 886-887.
14.
Flanigan, T. P., Rich, J. D.,& SpauldingA. (1999). HIV care among incarcerated persons: A missed opportunity. AIDS, 13(17), 2475-2476.
15.
Ghys, P. D., FransenK., Diallo, M. O., Ettiegne-TraoreV., Coulibaly, I. M., Yeboue, K. M., et al. (1997). The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d’Ivoire. AIDS, 11, F85-F93.
16.
Hammett, T. M., WidomR., EpsteinJ., GrossM., SifreS.,& EnosT. (1995). Issues and practices, 1994 update: HIV/AIDS and STDs in correctional facilities (NCJ 156832). Washington, DC: U.S. Department of Justice, National Institute of Justice.
17.
HogbenM., & St. Lawrence, J. S. (2000). HIV/STD risk reduction interventions in prison settings. Journal of Women’s Health & Gender-Based Medicine, 9(6), 587-592.
18.
Klausner, J. D., Baer, J. T., Contento, K. M., & BolanG. (1999). Investigation of a suspected outbreak of vaginal trichomoniasis among female inmates. Sexually Transmitted Diseases, 26(6), 335-338.
19.
Maruschak, L. M. (2001, July). HIV in prisons and jails, 1999 (Bureau of Justice Statistics Bulletin, NCJ 187456). Washington, DC: U.S. Department of Justice, Office of Justice Programs.
20.
National Commission on Correctional Health Care. (1994, September). Women’s Health Care in Correctional Settings (Position Statement). Chicago: SAGE Publications. Adopted September 25, 1994; updated post-1997.
21.
Parece, M. S., Herrera, G. A., Voigt, R. F., Middlekauff, S. L., & Irwin, K. L. (1999). STD testing policies and practices in U.S. city and county jails. Sexually Transmitted Diseases, 26(8), 431-437.
22.
PolonskyS., KerrS., HarrisB., GaiterJ., Fichtner, R. R., & Kennedy, M. G. (1994). HIV prevention in prisons and jails: Obstacles and opportunities. Public Health Reports, 109(5), 615-625.
23.
Quinn, T. C., Wawer, M. J., SewankamboN., SerwaddaD., LiC., Wabwire-MangenF., et al. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type. J. New England Journal of Medicine, 342, 921-929.
24.
RotchfordK., Sturm, A. W., & WilkinsonD. (2000). Effect of co-infection with sexually transmitted diseases (STDs) and of STD treatment on HIV shedding in genital secretions: Systematic review and data synthesis. Sexually Transmitted Diseases, 27, 243-248.
25.
Vigilante, K. C., Flynn, M. M., Affleck, P. C., Stunkle, J. C., Merriman, N. A., Flanigan, T. P., et al. (1999). Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning. Journal of Women’s Health, 8(3), 409-415.
26.
Wang, C. C., McClelland, R. S., ReillyM., OverbaughJ., Emery, S. R., MandaliyaK., et al. (2000). The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. Journal of Infectious Diseases, 183, 1017-1022.
27.
Wasserheit, J. N. (1992). Epidemiological synergy: Interrelationships between HIV infection and other sexually transmitted diseases. Sexually Transmitted Diseases, 19, 61-77.
28.
Wilson, D. J. (2000, May). Drug use, testing, and treatment in jails (Bureau of Justice Statistics Special Report, NCJ 179999). Washington, DC: U.S. Department of Justice, Office of Justice Programs.
